195 related articles for article (PubMed ID: 32054458)
1. Recurrent epileptic seizures following cardiac catheterization with iodixanol: a case report.
Lei P; He W; Shi Q; Sun M; Sun Z
BMC Cardiovasc Disord; 2020 Feb; 20(1):79. PubMed ID: 32054458
[TBL] [Abstract][Full Text] [Related]
2. Contrast-induced encephalopathy following cardiac catheterization.
Spina R; Simon N; Markus R; Muller DW; Kathir K
Catheter Cardiovasc Interv; 2017 Aug; 90(2):257-268. PubMed ID: 27896904
[TBL] [Abstract][Full Text] [Related]
3. Flow diagram of the differential diagnosis and clinical decision making in a rare case of contrast-induced encephalopathy following cardiac catheterization: a case report.
Sun J; Yuan L; Yu H; Yang Y; Zhou Z; Jia D; Zhou Y; Yang S
BMC Cardiovasc Disord; 2023 Jun; 23(1):280. PubMed ID: 37259072
[TBL] [Abstract][Full Text] [Related]
4. Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.
Hiremath S; Akbari A; Wells GA; Chow BJW
Int Urol Nephrol; 2018 Aug; 50(8):1477-1482. PubMed ID: 29687326
[TBL] [Abstract][Full Text] [Related]
5. Cortical blindness after cardiac catheterization: effect of rechallenge with dye.
Rama BN; Pagano TV; DelCore M; Knobel KR; Lee J
Cathet Cardiovasc Diagn; 1993 Feb; 28(2):149-51. PubMed ID: 8448799
[TBL] [Abstract][Full Text] [Related]
6. Focal seizure and cerebral contrast retention after cardiac catheterization.
Frye RE; Newburger JW; Nugent A; Sahin M
Pediatr Neurol; 2005 Mar; 32(3):213-6. PubMed ID: 15730907
[TBL] [Abstract][Full Text] [Related]
7. A case of contrast-induced encephalopathy using iodixanol.
Chisci E; Setacci F; de Donato G; Setacci C
J Endovasc Ther; 2011 Aug; 18(4):540-4. PubMed ID: 21861745
[TBL] [Abstract][Full Text] [Related]
8. Contrast administration in pediatric cardiac catheterization: dose and adverse events.
Senthilnathan S; Gauvreau K; Marshall AC; Lock JE; Bergersen L
Catheter Cardiovasc Interv; 2009 May; 73(6):814-20. PubMed ID: 19133670
[TBL] [Abstract][Full Text] [Related]
9. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
[TBL] [Abstract][Full Text] [Related]
10. Case report and literature review on contrast-induced encephalopathy.
Hamra M; Bakhit Y; Khan M; Moore R
Future Cardiol; 2017 Jul; 13(4):331-335. PubMed ID: 28621151
[TBL] [Abstract][Full Text] [Related]
11. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
[TBL] [Abstract][Full Text] [Related]
12. Experiences with iohexol and iodixanol during cardioangiography in an unselected patient population.
Flinck A; Gottfridsson B
Int J Cardiol; 2001; 80(2-3):143-51. PubMed ID: 11578707
[TBL] [Abstract][Full Text] [Related]
13. Contrast-induced nephropathy and cardiac catheterization: evidence in support of using the iso-osmolar contrast agent iodixanol in patients with renal dysfunction.
Ilkhanoff L; Carver J
J Invasive Cardiol; 2005 Apr; 17(4):216-7. PubMed ID: 15831976
[No Abstract] [Full Text] [Related]
14. Clinical and EEG features of seizures in adults with down syndrome.
Lefter S; Costello DJ; McNamara B; Sweeney B
J Clin Neurophysiol; 2011 Oct; 28(5):469-73. PubMed ID: 21946360
[TBL] [Abstract][Full Text] [Related]
15. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
Sutton AG; Finn P; Grech ED; Hall JA; Stewart MJ; Davies A; de Belder MA
Am Heart J; 2001 Apr; 141(4):677-83. PubMed ID: 11275937
[TBL] [Abstract][Full Text] [Related]
16. A Singular Manifestation of Contrast-induced Encephalopathy Following Coronary Angiography.
Riahi L; Mediouni M; Messelmani M; Fehri W
Neurol India; 2019; 67(6):1525-1527. PubMed ID: 31857552
[TBL] [Abstract][Full Text] [Related]
17. Recurrent contrast-induced encephalopathy following coronary angiography.
Spina R; Simon N; Markus R; Muller DW; Kathir K
Intern Med J; 2017 Feb; 47(2):221-224. PubMed ID: 28201864
[TBL] [Abstract][Full Text] [Related]
18. Protected Rotational Atherectomy With Double-Guiding Catheter Technique for Unprotected Distal Left Main.
Medda M; Casilli F; Bande M; Tespili M
JACC Cardiovasc Interv; 2019 Feb; 12(4):e27-e29. PubMed ID: 30711554
[No Abstract] [Full Text] [Related]
19. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
20. Bail-out directional atherectomy for abrupt coronary artery occlusion following conventional angioplasty.
McKeever LS; Marek JC; Kerwin PM; Cahill JM; Barr LA; Enger EL
Cathet Cardiovasc Diagn; 1993; Suppl 1():31-6. PubMed ID: 8324814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
